Method Article

Assessment of Knee Hyperalgesia in Mice using Pressure Application Measurement

DOI:

10.3791/68480

June 13th, 2025

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The protocol describes how to measure knee hyperalgesia in mice. We show examples in mouse models of acute knee pain as well as in models of osteoarthritis (OA).

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Assessment of knee hyperalgesia provides a robust assay for measuring peripheral sensitization in the knee, and represents a clinically relevant pain-dependent behavior that can be used in rodent models of arthritis. Several methods have been reported to determine the threshold for responses to knee compression in rodents. Here, we aimed to adapt existing methods to develop a standardized method for assessing knee hyperalgesia in adult mice, using a Pressure Application Measurement (PAM) device. The protocol includes detailed steps, training recommendations for new experimenters, and tips for achieving consistent results. We provide suggestions for optimal training of a new experimenter. Finally, representative outcomes are provided for both acute models of transient hyperalgesia and experimental osteoarthritis (OA) models, which are characterized by chronic pain. This method is highly sensitive to pharmacological interventions, making it suitable for evaluating the effects of mediators like cytokines and for medium-throughput drug screening assays. In summary, the described approach provides a robust and clinically relevant method for quantifying knee hyperalgesia.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Osteoarthritis (OA), the most common form of arthritis, is characterized by progressive cartilage degradation, synovitis, bone remodeling, and osteophyte growth1, and presents clinically as pain and loss of joint function. OA is one of the major sources of chronic pain in the world, profoundly impacting patients' lives due to reduced mobility and associated health issues such as anxiety and depression2,3. Commonly prescribed drugs for OA pain include nonsteroidal anti-inflammatory drugs (NSAIDs), visco-supplementation, corticosteroids, and opioids, but their efficacy is limited, and their prolonged use is associated with serious adverse effects or risk of addiction1,4.

In recent years, large cohort studies have attempted to carefully describe the pain experienced during progressive OA5. As part of this effort, several studies have performed quantitative sensory testing (QST) in subjects with OA, with the overall goal of identifying sensitization and determining associations between QST measures and OA symptoms and severity, as well as response to treatment (reviewed in6). The International Association for the Study of Pain defines sensitization as an increased responsiveness of nociceptive neurons to their normal input, and/or recruitment of a response to normally subthreshold inputs7. It is becoming increasingly clear that sensitization is a key process underlying chronic pain in OA. One particular QST finding that robustly distinguishes subjects with symptomatic OA from controls is a reduction in pain pressure threshold (PPT). A meta-analysis of PPT values (both at the knee and sites distant from the knee) of 1,003 participants with and without knee OA reported a significant standard mean difference (SMD, difference in means divided by standard deviation) in PPT between persons with OA and controls8.

The observation that OA patients display sensitization to mechanical stimuli, which is manifested as lowered pain pressure thresholds when a force is applied to the joint, suggests underlying mechanisms of peripheral and central sensitization that result from changes in the pain pathway6. The molecular and cellular underpinnings of these changes can be studied in rodent models of OA. In recent years, sophisticated mouse models have been developed to model the slowly progressive nature of knee OA, and this approach has revealed that distinct pain mechanisms operate in a time-dependent manner, which may have important translational significance9. For example, in the course of surgically induced experimental knee OA, mice develop mechanical allodynia in the operated hind paw early on in the course of the disease, while weight-bearing deficits only become apparent in late-stage disease9.

As in patients with OA, mice with experimental OA develop a lowered pain threshold for pain applied to the knee early on in the course of experimental knee OA10. This is indicative of sensitization of knee-innervating nociceptors, which can indeed be visualized and quantified by in vivo calcium imaging of the lumbar dorsal root ganglia11. Assessment of knee hyperalgesia provides a robust and relatively straightforward assay for measuring peripheral sensitization, thus representing a clinically relevant pain-dependent behavior that can be used in rodent models of arthritis. Several methods have been reported to determine the threshold for responses to knee compression in rodents. Older studies report squeezing the knee between the thumb and the forefinger, and recording a subjective withdrawal response or a vocalization response in the animal12,13,14 In 2007, Barton et al. reported pressure application measurement (PAM) as a novel behavioral technique to record mechanical hypersensitivity at the rat knee in inflammatory arthritis15. The method was subsequently validated in mice with antigen-induced arthritis of the knee 16. PAM is a technique that uses a force transducer to put an increasing force on the affected knee while providing visual feedback, thus enabling compression of the knee in a reproducible manner, which increases its sensitivity and reproducibility. These two previously published studies focused on models of inflammatory arthritis, where knee swelling is prominent. Therefore, we aimed to adapt these methods15,16 to develop a standardized method for assessing knee hyperalgesia in mice, which can be readily applied to models of OA and is highly responsive to pharmacological intervention, as described here.

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

All experimental protocols were approved under the category E by the Rush University Institutional Animal Care and Use Committee. The protocol described is to assess knee hyperalgesia in the right knee in response to a mechanical stimulus in adult C57BL/6 mice (10 weeks- 2 years of age) of either sex. To measure knee hyperalgesia in the left knee, switch hands.

1. Setting up the Pressure Application Measurement (PAM) device

  1. Connect one cable from the PAM device to the computer and the second cable from the PAM device to the force transducer.
  2. Turn on the computer and start the PAM software. Set the maximum pressure to 450 g.
    NOTE: The software and small transducer can measure up to 500 g. Therefore, the experimenter can choose a plateau anywhere between 450 g and 500 g, but the maximum cutoff should not change within an experiment.
  3. Leave the mice in the testing room for 15-30 min until they are acclimatized and have settled down. Ensure that the testing room is a separate room from where the mice are housed and that the room is quiet. Use the same testing room throughout the study.
  4. Perform pre-acclimatization, if needed, to calm mice down before the study is started - in this case, restrain the animals by holding the mouse in the left hand, by restraining the back and firmly holding the tail down with the 4th and 5th fingers (as they would be for the test), 2 days before the first testing day in order to acclimatize the mice to the assay. Within a given experiment, acclimatize all mice the same way.
  5. After the acclimatization, ensure the mouse is calm and does not wriggle when restrained. If the mouse is not calm, return it to its cage and postpone testing for a few days.

2. Training for measurement of knee hyperalgesia

  1. Start with naïve animals and learn how to recognize responses when the animals are calm. This will inform the experimenter to recognize what a normal response is for that assay.
  2. Use an experimental model where knee hyperalgesia has been characterized by an experienced tester to know what to expect. Recognize that in experimental OA, the responses may be less obvious than in acute models or inflammatory models.
  3. Use lidocaine or an opiate in order to reverse the pain behavior - this will help to assess how to tell the difference between a stress response versus a real pain-related response.
  4. Perform all testing in a manner blinded to group allocation. Perform an OA model experiment with known analgesics in a vehicle-controlled experiment. Confirm that the tester can distinguish these groups and get reproducible measurements.
  5. Expect that completing the training may take several weeks.

3. Baseline measurement of knee hyperalgesia using PAM

NOTE: Many experimental models of inflammatory arthritis or osteoarthritis are unilateral (for example, surgically induced knee OA). To assess knee hyperalgesia in these models, we always measure knee withdrawal threshold first in the contralateral knee of all the mice to be tested. After that, we test the ipsilateral knee. As an example, this protocol can be applied to measure knee hyperalgesia in experimental OA induced by DMM. In this model, joint damage is accompanied by knee hyperalgesia, developing by week 2 after surgery, and maintained up to week 1617.

  1. Cradle the mouse in the left hand, restraining the back and firmly holding the tail down with the 4th and 5th fingers.
  2. Loop the index finger of the other hand (right hand) through the tie of the transducer (Figure 1A). Then, place the index finger with the transducer into a transparent plastic bag (e.g., a sandwich bag). This will prevent the transducer from getting soiled, for example, by mouse urine.
    NOTE: The transducer is fragile and easily breaks if it is not protected from liquids or when too high a force is applied.
  3. Using the right thumb and middle finger, take hold of the right leg and use the middle finger to gently pin the paw down onto the thenar of the left hand (Figure 1B). The correct position of the knee at the start of testing is around 90° flexion.
  4. With the knee in 90° flexion, the right thumb touches the lateral side of the knee. With the index finger touching the medial side of the transducer, slowly apply pressure against the knee. As directed by the computer software (blue line on the graph), apply increasing force at a constant rate (30 g/s), up to 450 g or until the mouse shows pain-related behaviors such as vocalization, muscle twitching, body wriggling, or whisker movement.
  5. Once the mouse shows pain-related behavior, retract the finger with the transducer from the knee and record the pressure displayed on the screen (Figure 1C). If the mouse does not display pain-related behavior when 450 g is reached, still let go of the transducer and assign a value of 450 g as the withdrawal threshold for that test.
    NOTE: Each individual mouse expresses a pain response in its own way. Therefore, the tester has to determine which pain-related behaviors individual mice express. However, some mice do not express pain-related behaviors at all, and in this case, the tester can either re-test the contralateral knee to determine that mouse's individual pain response a couple of days later or continue to measure the ipsilateral side and determine the behavior pattern. The latter option requires many hours of experience, so the first option is recommended for a beginner.
  6. Return the mouse to the cage and proceed to test the next mouse. When one knee has been tested in all the mice, go back to the first mouse and repeat the testing. Test each knee 2x and take an average of the two test results as the final result. This number is termed the withdrawal threshold.
    1. If there is a difference of ≥ 60 g between the 1st and 2nd measurements, take a 3rd measurement and use the average of the three measurements as the final result. Try not to stress out the mice and avoid multiple consecutive measurements in the same mouse. This is why there has to be some time between each consecutive measurement.
  7. Test knee hyperalgesia under blind conditions in order to avoid bias. Use individual ear tags to facilitate blinding. Determining whether the mouse's behavior is indicative of pain requires practice, experience, and confidence because the tester has to use their judgment. This is why blinding to experimental groups is important.

4. Measuring knee hyperalgesia in a model of acute knee pain

  1. After baseline measurement of knee hyperalgesia, shave the fur around the knee.
  2. Anesthetize the animal with isoflurane and check proper anesthesia using the toe pinch reflex. Use vet ointment on the eyes to prevent dryness while under anesthesia. Inject 5 µL of Pam3CSK4 (1 µg or 3 µg dissolved in sterile water) or vehicle control (5 µL) through the patellar tendon into the intra-articular space of the right or left knee, using a Hamilton syringe with a 30G needle.
  3. Assess knee hyperalgesia 1 h, 2 h, 4 h, 6 h, and 24 h after the injection under blinded conditions.
  4. To assess the effect of lidocaine, inject either lidocaine (20 mg/kg in saline) or saline intraarticularly 4 h after injection of Pam3CSK4. Then, assess knee hyperalgesia after  0.5 h, 2 h, and 20 h.

5. Longitudinal assessment of knee hyperalgesia in a protracted model of OA

  1. Assess baseline knee hyperalgesia in male 12-week-old C57BL/6 mice.
  2. Perform destabilization of the medial meniscus (DMM) or sham surgery in one knee, as described in18.
  3. Assess knee hyperalgesia at 2 weeks, 4 weeks, 8 weeks, 12 weeks, and 16 weeks after surgery.
  4. To assess the effect of intra-articular lidocaine, assess knee hyperalgesia 4 weeks after DMM, and then inject lidocaine (20 mg/kg in 5 µL) or saline under isoflurane anesthesia as described in step 4.
  5. Assess knee hyperalgesia 20 min, 120 min, and 240 min after lidocaine injection.

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Time course of knee hyperalgesia in a model of acute knee pain
All results shown have been previously reported by our group, and we refer to10for a detailed description. The first example shows a model for inducing acute, transient knee hyperalgesia. In this experiment, we injected Pam3CSK4, a synthetic toll-like receptor 2 (TLR2) ligand (1 µg or 3 µg, dissolved in sterile water) at 5 µL, into the knee cavity of 10-week-old naïve male C57BL/6 mice, using a Hamilton syringe wit...

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Measurement of knee hyperalgesia in mice offers a relatively fast and straightforward means of assessing knee hyperalgesia associated with experimental arthritis. As can be observed from the representative results shown, the assay can detect acute onset and transient hyperalgesia (Figure 2A). We have reported this behavior in response to several mediators injected into the knee joint, including an aggrecan fragment10, a neurotrophin, nerve growth factor (NGF)

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

AMM is a consultant for Novartis, Merck, Roivant, and Averitas. She has received research support from Orion and Eli Lilly. SI and REM have nothing to disclose.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Our research is funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, Grant/Award Numbers: P30AR079206 (AMM), R01AR060364 (AMM), R01AR064251 (AMM), UC2AR082186 (AMM), R21AR085242-01 (AMM), and R01AR077019 (REM).

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
C-C chemokine 2 receptor antagonist (CCR2RA)TocrisRS 504393
computer (any type)windows 7 minimum
LidocaineSigmaL5647
Pressure Application Measurement (P.A.M)Ugo Basile38500included transducer, computer, cables
sandwich bagwhole food market6-1/2 x 5-7/8cover the transducer
toll-like receptor 2 ligand Pam3CSK4invitrogentlrl-pms

References

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Tang, S., et al. Osteoarthritis. Nat Rev Dis Primers. 11 (1), 10(2025).
  2. Allen, K. D., Thoma, L. M., Golightly, Y. M. Epidemiology of osteoarthritis. Osteoarthritis Cartilage. 30 (2), 184-195 (2022).
  3. Schmukler, J., et al. 36-40% of Routine Care Patients With Osteoarthritis or Rheumatoid Arthritis Screen Positive for Anxiety, Depression, and/or Fibromyalgia on a Single MDHAQ. ACR Open Rheumatol. 6 (10), 641-647 (2024).
  4. Smith, S. R., Deshpande, B. R., Collins, J. E., Katz, J. N., Losina, E. Comparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis: systematic analytic review. Osteoarthritis Cartilage. 24 (6), 962-972 (2016).
  5. Neogi, T. The epidemiology and impact of pain in osteoarthritis. Osteoarthritis Cartilage. 21 (9), 1145-1153 (2013).
  6. Arant, K. R., Katz, J. N., Neogi, T. Quantitative sensory testing: identifying pain characteristics in patients with osteoarthritis. Osteoarthritis Cartilage. 30 (1), 17-31 (2022).
  7. Loeser, J. D., Treede, R. D. The Kyoto protocol of IASP Basic Pain Terminology. Pain. 137 (3), 473-477 (2008).
  8. Fingleton, C., et al. Pain sensitization in people with knee osteoarthritis: a systematic review and meta-analysis. Osteoarthritis Cartilage. 23 (7), 1043-1056 (2015).
  9. Miller, R. E., Malfait, A. M. Osteoarthritis pain: What are we learning from animal models. Best Pract Res Clin Rheumatol. 31 (5), 676-687 (2017).
  10. Miller, R. E., et al. An aggrecan fragment drives osteoarthritis pain through Toll-like receptor 2. JCI Insight. 3 (6), e95704(2018).
  11. Miller, R. E., et al. Visualization of Peripheral Neuron Sensitization in a Surgical Mouse Model of Osteoarthritis by In Vivo Calcium Imaging. Arthritis Rheumatol. 70 (1), 88-97 (2018).
  12. Gauldie, S. D., et al. A robust model of adjuvant-induced chronic unilateral arthritis in two mouse strains. J Neurosci Methods. 139 (2), 281-291 (2004).
  13. Knights, C. B., Gentry, C., Bevan, S. Partial medial meniscectomy produces osteoarthritis pain-related behaviour in female C57BL/6 mice. Pain. 153 (2), 281-292 (2012).
  14. Yu, Y. C., et al. Two variables that can be used as pain indices in experimental animal models of arthritis. J Neurosci Methods. 115 (1), 107-113 (2002).
  15. Barton, N. J., et al. Pressure application measurement (PAM): a novel behavioural technique for measuring hypersensitivity in a rat model of joint pain. J Neurosci Methods. 163 (1), 67-75 (2007).
  16. Leuchtweis, J., et al. Validation of the digital pressure application measurement (PAM) device for detection of primary mechanical hyperalgesia in rat and mouse antigen-induced knee joint arthritis. Methods Find Exp Clin Pharmacol. 32 (8), 575-583 (2010).
  17. Miller, R. E., et al. Chemogenetic Inhibition of Pain Neurons in a Mouse Model of Osteoarthritis. Arthritis Rheumatol. 69 (7), 1429-1439 (2017).
  18. Glasson, S. S., Blanchet, T. J., Morris, E. A. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage. 15 (9), 1061-1069 (2007).
  19. Obeidat, A. M., et al. Piezo2 expressing nociceptors mediate mechanical sensitization in experimental osteoarthritis. Nat Commun. 14 (1), 2479(2023).
  20. Wang, L., et al. Notch signaling is activated in knee-innervating dorsal root ganglia in experimental models of osteoarthritis joint pain. Arthritis Res Ther. 25 (1), 63(2023).
  21. Obeidat, A. M., et al. Intra-articular sprouting of nociceptors accompanies progressive osteoarthritis: comparative evidence in four murine models. Front Neuroanat. 18, 1429124(2024).
  22. Geraghty, T., et al. Acute systemic macrophage depletion in osteoarthritic mice alleviates pain-related behaviors and does not affect joint damage. Arthritis Res Ther. 26 (1), 224(2024).
  23. Bergman, R. F., et al. Sexual dimorphism of the synovial transcriptome underpins greater PTOA disease severity in male mice following joint injury. Osteoarthritis Cartilage. 32 (9), 1060-1073 (2024).
  24. Geraghty, T., et al. Age-Associated Changes in Knee Osteoarthritis, Pain-Related Behaviors, and Dorsal Root Ganglia Immunophenotyping of Male and Female Mice. Arthritis Rheumatol. 75 (10), 1770-1780 (2023).
  25. Ishihara, S., et al. The role of intra-articular neuronal CCR2 receptors in knee joint pain associated with experimental osteoarthritis in mice. Arthritis Res Ther. 23 (1), 103(2021).
  26. Liu, H., et al. Sirt5 regulates chondrocyte metabolism and osteoarthritis development through protein lysine malonylation. bioRxiv. , (2024).

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Knee HyperalgesiaPressure Application MeasurementOsteoarthritis PainMouse Pain AssayPeripheral SensitizationPain ThresholdIntraarticular InjectionDMM SurgeryPain BehaviorDrug Screening

Related Articles